To include your compound in the COVID-19 Resource Center, submit it here.

Sanofi discontinues Zika program after BARDA pulls funding

Sanofi (Euronext:SAN; NYSE:SNY) said it will discontinue development of its inactivated Zika vaccine after HHS's Biomedical Advanced Research and Development Authority pulled its funding from the program

Read the full 271 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE